Diana Severynse-Stevens

Senior Director, Drug Development, Global Health

Diana Severynse-Stevens

Education

  • PhD, Microbiology, University of North Carolina at Chapel Hill
  • BS, Biology, State University of New York, Binghamton

Diana M. Severynse-Stevens, PhD, has more than 15 years of experience in the pharmaceutical industry, and more than 20 years of experience in product development, including work in drug discovery, preclinical and clinical drug development. She provides regulatory guidance and expertise to clients in preclinical and clinical development of pharmaceuticals.

Dr. Severynse-Stevens has focused her work on projects supporting translational research in several therapeutic areas including infectious, metabolic and cardiovascular diseases. She has helped to identify and manage contract research organizations, analyze data, and track activities and timing for these projects.

Previously, she worked at DARA Biosciences, Nobex Corporation, Wyeth-Ayerst Pharmaceuticals, and Procter & Gamble Pharmaceuticals. She has an extensive background in program management, clinical and regulatory writing, and pharmacology.